There are 2789 resources available
1788P - Physician-reported strategies for overcoming barriers to NGS testing in oncology care
Presenter: Ning Ning
Session: ePoster Display
1789P - The gamma secretase inhibitor AL101 combined with other drugs for dual targeting of Notch dysregulated tumors
Presenter: Renata Ferrarotto
Session: ePoster Display
1790P - Single-cell ex vivo drug response testing platform on fluid samples from patients with solid tumors
Presenter: Lorenz Bankel
Session: ePoster Display
1791P - A phase I pharmacology study of the dual MDMX/MDM2 inhibitor, ALRN 6924, in healthy volunteers
Presenter: Christine Voors-Pette
Session: ePoster Display
1731P - The landscape of BRAF alteration in Chinese solid tumor patients
Presenter: Yongjie Wang
Session: ePoster Display
1733P - Analysis of chemotherapy (Ct) efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p)
Presenter: Susana Cedres
Session: ePoster Display
1650P - Adoption and early clinical outcomes of atezolizumab (atezo) + carboplatin and etoposide (CE) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the real-world (RW) setting
Presenter: David Chun Cheong Tsui
Session: ePoster Display
1651P - Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
Presenter: Toshiaki Takahashi
Session: ePoster Display
1652P - Safety of simultaneously performed radiotherapy in patients with small cell lung cancer undergoing atezolizumab treatment
Presenter: Julia Galuba
Session: ePoster Display
1742TiP - RADIORYTHMIC: Phase III, opened, randomized study of post-operative radiotherapy (PORT) versus surveillance in stage IIb/III of Masaoka Koga thymoma after complete surgical resection
Presenter: Clemence Basse
Session: ePoster Display